Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

Neuroinflammation has received increased attention as a target for putative neuroprotective therapies in Parkinson’s Disease (PD). Two prototypic pro-inflammatory cytokines interleukin-1β (IL-1) and tumor necrosis factor-α (TNF) have been implicated as main effectors of the functional consequences o...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, María C., Casabona, Juan C., Puntel, Mariana, Pitossi, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638129/
https://www.ncbi.nlm.nih.gov/pubmed/23641196
http://dx.doi.org/10.3389/fncel.2013.00053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638129/
https://www.ncbi.nlm.nih.gov/pubmed/23641196
http://dx.doi.org/10.3389/fncel.2013.00053

Ejemplares similares